| 0 |
UNABLE TO AFFORD PRESCRIBED MEDICATION |
1 |
0.0141 |
| 1 |
ACQUIRED DIAPHRAGMATIC EVENTRATION |
1 |
0.0028 |
| 2 |
ANISOCORIA |
1 |
0.0026 |
| 3 |
SKIN CHAPPED |
1 |
0.0025 |
| 4 |
EYE BURNS |
1 |
0.0017 |
| 5 |
ADRENAL SUPPRESSION |
1 |
0.0012 |
| 6 |
INTENTIONAL DEVICE USE ISSUE |
1 |
0.0012 |
| 7 |
COARCTATION OF THE AORTA |
1 |
0.0010 |
| 8 |
MIDDLE EAR EFFUSION |
2 |
0.0009 |
| 9 |
BLOOD CREATINE PHOSPHOKINASE MB INCREASED |
1 |
0.0008 |
| 10 |
CORNEAL ABRASION |
1 |
0.0007 |
| 11 |
AKINESIA |
1 |
0.0005 |
| 12 |
HAEMATOCRIT INCREASED |
1 |
0.0004 |
| 13 |
SINUS PAIN |
1 |
0.0004 |
| 14 |
BREATH ODOUR |
1 |
0.0004 |
| 15 |
BRONCHITIS CHRONIC |
1 |
0.0004 |
| 16 |
EAR CONGESTION |
1 |
0.0004 |
| 17 |
NICOTINE DEPENDENCE |
2 |
0.0003 |
| 18 |
CANDIDIASIS |
1 |
0.0002 |
| 19 |
SELF-MEDICATION |
1 |
0.0002 |
| 20 |
LUNG NEOPLASM |
1 |
0.0002 |
| 21 |
TONGUE DISCOLOURATION |
1 |
0.0002 |
| 22 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 23 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 24 |
INJECTION SITE PAPULE |
1 |
0.0002 |
| 25 |
INCREASED UPPER AIRWAY SECRETION |
1 |
0.0002 |
| 26 |
ASTHENOPIA |
1 |
0.0002 |
| 27 |
OCULAR DISCOMFORT |
2 |
0.0002 |
| 28 |
VENTRICULAR SEPTAL DEFECT |
1 |
0.0002 |
| 29 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 30 |
POOR QUALITY DRUG ADMINISTERED |
1 |
0.0002 |
| 31 |
TONGUE DISORDER |
1 |
0.0001 |
| 32 |
FEELING DRUNK |
1 |
0.0001 |
| 33 |
DISSOCIATION |
1 |
0.0001 |
| 34 |
CONGENITAL ANOMALY |
1 |
0.0001 |
| 35 |
APHTHOUS ULCER |
1 |
0.0001 |
| 36 |
MIOSIS |
1 |
0.0001 |
| 37 |
PHOTOSENSITIVITY REACTION |
2 |
0.0001 |
| 38 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 39 |
TOOTHACHE |
2 |
0.0001 |
| 40 |
SINUS DISORDER |
2 |
0.0001 |
| 41 |
DRY THROAT |
1 |
0.0001 |
| 42 |
SLUGGISHNESS |
1 |
0.0001 |
| 43 |
EUPHORIC MOOD |
1 |
0.0001 |
| 44 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 45 |
EAR DISCOMFORT |
1 |
0.0001 |
| 46 |
INTENTIONAL DRUG MISUSE |
2 |
0.0001 |
| 47 |
INJECTION SITE NODULE |
1 |
0.0001 |
| 48 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 49 |
OROPHARYNGEAL PAIN |
8 |
0.0001 |
| 50 |
SPINAL PAIN |
1 |
0.0001 |
| 51 |
BURSITIS |
1 |
0.0001 |
| 52 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 53 |
APHONIA |
1 |
0.0001 |
| 54 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 55 |
PAIN IN JAW |
2 |
0.0001 |
| 56 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 57 |
APHASIA |
2 |
0.0001 |
| 58 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 59 |
PRODUCTIVE COUGH |
3 |
0.0001 |
| 60 |
HEART RATE DECREASED |
2 |
0.0001 |
| 61 |
THINKING ABNORMAL |
1 |
0.0001 |
| 62 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 63 |
FEELING JITTERY |
1 |
0.0001 |
| 64 |
PRODUCT QUALITY ISSUE |
7 |
0.0001 |
| 65 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 66 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 67 |
STOMATITIS |
3 |
0.0000 |
| 68 |
TASTE DISORDER |
1 |
0.0000 |
| 69 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 70 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 71 |
RHINORRHOEA |
3 |
0.0000 |
| 72 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 73 |
THROAT IRRITATION |
2 |
0.0000 |
| 74 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 75 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 76 |
AGEUSIA |
1 |
0.0000 |
| 77 |
HYPOPHAGIA |
1 |
0.0000 |
| 78 |
DRUG RESISTANCE |
1 |
0.0000 |
| 79 |
DEAFNESS |
1 |
0.0000 |
| 80 |
DRY MOUTH |
3 |
0.0000 |
| 81 |
EYE PAIN |
2 |
0.0000 |
| 82 |
FLATULENCE |
2 |
0.0000 |
| 83 |
HYPERSOMNIA |
1 |
0.0000 |
| 84 |
PRODUCT SUBSTITUTION ISSUE |
2 |
0.0000 |
| 85 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 86 |
WHEEZING |
2 |
0.0000 |
| 87 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 88 |
COUGH |
9 |
0.0000 |
| 89 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 90 |
EYE DISORDER |
1 |
0.0000 |
| 91 |
GAIT INABILITY |
1 |
0.0000 |
| 92 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 93 |
ANGER |
1 |
0.0000 |
| 94 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 95 |
RASH MACULAR |
1 |
0.0000 |
| 96 |
PANIC ATTACK |
1 |
0.0000 |
| 97 |
BRONCHITIS |
2 |
0.0000 |
| 98 |
EYE SWELLING |
1 |
0.0000 |
| 99 |
THROMBOSIS |
2 |
0.0000 |
| 100 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 101 |
OSTEOPOROSIS |
1 |
0.0000 |
| 102 |
POLLAKIURIA |
1 |
0.0000 |
| 103 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 104 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 105 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 106 |
VISION BLURRED |
3 |
0.0000 |
| 107 |
TINNITUS |
1 |
0.0000 |
| 108 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 109 |
CONTUSION |
2 |
0.0000 |
| 110 |
FLUID RETENTION |
1 |
0.0000 |
| 111 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 112 |
THERAPY CESSATION |
1 |
0.0000 |
| 113 |
INFLAMMATION |
1 |
0.0000 |
| 114 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 115 |
OEDEMA |
1 |
0.0000 |
| 116 |
MEDICATION ERROR |
1 |
0.0000 |
| 117 |
NECK PAIN |
1 |
0.0000 |
| 118 |
BLISTER |
1 |
0.0000 |
| 119 |
DYSPHONIA |
1 |
0.0000 |
| 120 |
PALPITATIONS |
2 |
0.0000 |
| 121 |
CHILLS |
2 |
0.0000 |
| 122 |
NASAL CONGESTION |
1 |
0.0000 |
| 123 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 124 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 125 |
AMNESIA |
1 |
0.0000 |
| 126 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 127 |
INSOMNIA |
4 |
0.0000 |
| 128 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 129 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 130 |
HALLUCINATION |
1 |
0.0000 |
| 131 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 132 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 133 |
ARTHRITIS |
1 |
0.0000 |
| 134 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 135 |
PNEUMONIA |
4 |
0.0000 |
| 136 |
TREMOR |
2 |
0.0000 |
| 137 |
BALANCE DISORDER |
1 |
0.0000 |
| 138 |
TACHYCARDIA |
1 |
0.0000 |
| 139 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 140 |
CHEST PAIN |
2 |
0.0000 |
| 141 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 142 |
DYSPNOEA |
6 |
0.0000 |
| 143 |
DYSPHAGIA |
1 |
0.0000 |
| 144 |
MIGRAINE |
1 |
0.0000 |
| 145 |
HEART RATE INCREASED |
1 |
0.0000 |
| 146 |
FLUSHING |
1 |
0.0000 |
| 147 |
SINUSITIS |
1 |
0.0000 |
| 148 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 149 |
INFLUENZA |
1 |
0.0000 |
| 150 |
SEPSIS |
1 |
0.0000 |
| 151 |
ASTHMA |
1 |
0.0000 |
| 152 |
NAUSEA |
7 |
0.0000 |
| 153 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 154 |
SEIZURE |
1 |
0.0000 |
| 155 |
BACK PAIN |
2 |
0.0000 |
| 156 |
PAIN |
5 |
0.0000 |
| 157 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 158 |
DRUG INEFFECTIVE |
10 |
0.0000 |
| 159 |
DEHYDRATION |
1 |
0.0000 |
| 160 |
ARTHRALGIA |
3 |
0.0000 |
| 161 |
HOSPITALISATION |
1 |
0.0000 |
| 162 |
HEADACHE |
4 |
0.0000 |
| 163 |
PARAESTHESIA |
1 |
0.0000 |
| 164 |
DRUG INTERACTION |
1 |
0.0000 |
| 165 |
DIARRHOEA |
4 |
0.0000 |
| 166 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 167 |
DIZZINESS |
3 |
0.0000 |
| 168 |
MYALGIA |
1 |
0.0000 |
| 169 |
PYREXIA |
2 |
0.0000 |
| 170 |
COVID-19 |
1 |
0.0000 |
| 171 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 172 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 173 |
MUSCLE SPASMS |
1 |
0.0000 |
| 174 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 175 |
FATIGUE |
4 |
0.0000 |
| 176 |
SOMNOLENCE |
1 |
0.0000 |
| 177 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 178 |
ERYTHEMA |
1 |
0.0000 |
| 179 |
HYPERTENSION |
1 |
0.0000 |
| 180 |
RASH |
2 |
0.0000 |
| 181 |
CONSTIPATION |
1 |
0.0000 |
| 182 |
WEIGHT INCREASED |
1 |
0.0000 |
| 183 |
DECREASED APPETITE |
1 |
0.0000 |
| 184 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 185 |
VOMITING |
2 |
0.0000 |
| 186 |
FEELING ABNORMAL |
1 |
0.0000 |
| 187 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 188 |
ASTHENIA |
1 |
0.0000 |
| 189 |
PRURITUS |
1 |
0.0000 |
| 190 |
DEATH |
1 |
0.0000 |